SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-006373
Filing Date
2024-01-25
Accepted
2024-01-24 21:44:31
Documents
9

Document Format Files

Seq Description Document Type Size
1 S-3 tm243780-1_s3.htm S-3 276840
2 EXHIBIT 4.3 tm243780d2_ex4-3.htm EX-4.3 86752
3 EXHIBIT 4.4 tm243780d2_ex4-4.htm EX-4.4 85726
4 EXHIBIT 5.1 tm243780d2_ex5-1.htm EX-5.1 15210
5 EXHIBIT 10.1 tm243780d2_ex10-1.htm EX-10.1 221841
6 EXHIBIT 23.2 tm243780d2_ex23-2.htm EX-23.2 2243
7 EX-FILING FEES tm243780d2_ex-filingfees.htm EX-FILING FEES 16530
8 GRAPHIC tm243780d2_ex5-1img002.jpg GRAPHIC 7331
9 GRAPHIC lg_eloxxpharma-4clr.jpg GRAPHIC 14198
  Complete submission text file 0001104659-24-006373.txt   736460
Mailing Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472
Business Address 480 ARSENAL WAY SUITE 130 WATERTOWN MA 02472 781-577-5300
Eloxx Pharmaceuticals, Inc. (Filer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276686 | Film No.: 24558421
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)